[Treatment outcome of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies not in remission]

Zhonghua Zhong Liu Za Zhi. 2012 Feb;34(2):156-7. doi: 10.3760/cma.j.issn.0253-3766.2012.02.017.
[Article in Chinese]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Disease-Free Survival
  • Female
  • Graft vs Host Disease / etiology
  • Graft vs Host Disease / prevention & control
  • Hematologic Neoplasms / therapy*
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Leukemia, Myeloid, Acute / therapy
  • Lymphocyte Transfusion
  • Lymphoma, Non-Hodgkin / therapy
  • Male
  • Middle Aged
  • Recurrence
  • Survival Rate
  • Transplantation, Homologous
  • Young Adult